Medicare Enrolled

Dr. Omar Moinuddin, MD

Q: Does Dr. Moinuddin receive payments from pharmaceutical companies?

Yes. Dr. Moinuddin received a total of $3,193 from 12 companies across 35 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.

Q: What does Data Coverage mean?

Data Coverage (currently Moderate for Dr. Moinuddin) measures how much public federal data is available about a provider. It is not a quality rating. A Very High or High level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A Low or Moderate level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative.

Ophthalmology · Southlake, TX

305 MORRISON PARK DR STE 100, Southlake, TX 76092

8178656800

Registered in NPPES since 2019

NPI: 1477114296 verify on NPPES ↗

Moderate

DATA COVERAGE

Data in 3 of 4 federal sources

Measures public federal data availability — not provider quality

Informational, not a quality rating. This page presents federal public records about Dr. Moinuddin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →

Are you Dr. Moinuddin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Moinuddin

Dr. Omar Moinuddin is an ophthalmology specialist in Southlake, TX, with 7 years of NPI registration.

Between the years covered by Open Payments, Dr. Moinuddin received a total of $3,193 from 12 pharmaceutical and/or device companies across 35 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Moinuddin is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 7 years of NPI registration $3,193 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗

$3,193

Total received (2023-2024)

Avg $1,596/year across 2 years

Top 34% in TX for ophthalmology

A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.

Companies

Payment records

Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024

$2,676

2023

$516

Payments by company (2024)

EyePoint Pharmaceuticals US, Inc.

$1,205

Genentech USA, Inc.

$278

Alimera Sciences, Inc.

$243

Regeneron Healthcare Solutions, Inc.

$227

Apellis Pharmaceuticals, Inc.

$209

Astellas Pharma US Inc

$148

Coherus Biosciences Inc.

$130

ABBVIE INC.

$102

Bausch & Lomb Americas Inc.

$47

Astellas US LLC

$44

Sandoz Inc.

$29

Mallinckrodt Hospital Products Inc.

$14

Top 3 companies account for 64.5% of 2024 payments

All-time payments by company (2023-2024) ›

EyePoint Pharmaceuticals US, Inc.

$1,205

Genentech USA, Inc.

$441

Alimera Sciences, Inc.

$388

Apellis Pharmaceuticals, Inc.

$364

Regeneron Healthcare Solutions, Inc.

$227

Astellas Pharma US Inc

$176

Coherus Biosciences Inc.

$156

ABBVIE INC.

$102

Bausch & Lomb Americas Inc.

$47

Astellas US LLC

$44

Sandoz Inc.

$29

Mallinckrodt Hospital Products Inc.

$14

Top 3 companies account for 63.7% of all-time payments

Associated products mentioned in payments ›

ACTHAR · Cimerli · EYLEA HD · EYP-1901 · ILUVIEN · Izervay · OZURDEX · Susvimo · Syfovre · Vabysmo · XIPERE · YUTIQ

Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Looking for an ophthalmology specialist in Southlake?
Compare ophthalmologists in the Southlake area by procedure volume, costs, and industry payment transparency.

Browse ophthalmologists nearby

Geographic Context

Ophthalmologists in nearby ZIP areas

287

County median income

$81,905

Nearest hospital to ZIP centroid (approximate)

TEXAS HEALTH HARRIS METHODIST HOSPITAL SOUTHLAKE
0.0 mi

Data Sources

Provider Registry	✓ NPPES	NPPES snapshot; verify current record
Medicare Enrollment	✓ PECOS	PECOS snapshot
Practice Data	— No data	N/A
Industry Payments	✓ Open Payments	CY 2024
Disciplinary History	— Not included	N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Moinuddin is an ophthalmology specialist.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Moinuddin receive payments from pharmaceutical companies?

Yes. Dr. Moinuddin received a total of $3,193 from 12 companies across 35 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.

What does Data Coverage mean?

Data Coverage (currently Moderate for Dr. Moinuddin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →

Is this data up to date?

Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city

Ophthalmologists in Southlake

Browse ophthalmologists in Southlake ranked by procedure volume and transparency data.

Highest volume

Top Ophthalmologists in TX

Ophthalmologists ranked by total Medicare services performed statewide.

Industry payments

Pharma Payments to Ophthalmologists in TX

Which TX ophthalmologists receive the most from drug and device companies.

By company

EyePoint Pharmaceuticals US, Inc. Payments to Doctors

See all physicians who received payments from EyePoint Pharmaceuticals US, Inc.

By company

Genentech USA, Inc. Payments to Doctors

See all physicians who received payments from Genentech USA, Inc.

By company

Alimera Sciences, Inc. Payments to Doctors

See all physicians who received payments from Alimera Sciences, Inc.

About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology